Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant

Summary

This study is designed to look at the effect sitagliptin has on tacrolimus and sirolimus drug levels in kidney transplant patients. It is also designed to look at the side effects experienced in the transplant population.

Timeline

Start

2007-04

Primary completion

2011-01

Completion

2011-01

Drugs

Indications